Skip to main content

Moderna, Inc. (NASDAQ: MRNA) Investor Securities Class Action Lawsuit 08/09/2024

  • If you purchased a significant amount of shares of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25, 2024, and / or if you purchased any NASDAQ: MRNA shares prior to January 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 8, 2024. NASDAQ: MRNA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 09, 2024 - An investor in shares of Moderna, Inc. (NASDAQ: MRNA) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Moderna, Inc. in connection with certain allegedly false and misleading statements made between January 18, 2023 and June 25, 2024. Cambridge, MA based Moderna, Inc., a biotechnology c...



You must register (for free) or login to view the entire case.